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were measured before, immediately after and 24 hr after each bout. Cycle performance, heart 23 rate and blood pressure responses to exercise were also recorded. Whilst cycle performance 24 was modestly elevated in the second trial (6.5% increase in peak power output) there was no 25 difference in the cardiovascular, lactate or catecholamine response to the two cycle trials. 26 cTnI was not significantly elevated from baseline through recovery (Trial 1: 0.06±0.04 ng.ml -27 1 , 0.05±0.04 ng.ml -1 , 0.03±0.02 ng.ml -1 Trial 2: 0.02±0.04 ng.ml -1 , 0.04±0.03 ng.ml -1 , 28 0.05±0.06 ng.ml -1 ) in either trial. Very small within subject changes were not significantly 29 correlated between the two trials (r=0.06; p>0.05). We can conclude that short duration, high 30 intensity exercise does not elicit a clinically relevant response in cTnI and any small 31
Introduction 36
Recent scientific literature is replete with observations of elevated cardiac biomarkers during 37 and after prolonged endurance exercise [1, 2, 3, 4] . Different cardiac biomarkers reflect 38 different pathological and/or physiological processes but most attention in the sports 39 medicine literature has been paid to the exercise-related appearance of cardiac troponins 40 (cTnI and/or cTnT). cTnI/T are recognised as highly tissue-specific biomarkers of myocyte 41 cell insult [5] and are important in clinical decision making when acute cardiac events are 42 suspected [6] . An elevation in cTn either during or after exercise has, consequently, 43 generated both interest and concern in athletes, scientists and clinicians [4] . 44 45 An exercise-associated elevation in cTnI and/or cTnI has been reported after endurance 46 events lasting a couple of hours [7] through to multiple days [8] . The mechanism(s) 47 associated with exercise-related appearance of cTnI or T have not been proven but likely 48 relate to the unremitting cardiovascular work and associated changes in metabolic milieu of 49 the cardiomycocytes [4] . Most available data related to exercise-associated increases in cTnI 50 or cTnT have been produced from field-based studies with simple pre-post blood draws [4] . 51
This has limited our ability to interpret this data and the exact role that exercise plays. A 52 unique study was completed by Middleton et al. (2008) [9] whereby 9 marathon runners 53 completed a treadmill-based marathon run with blood taken every 30 min. This study 54 demonstrated an elevation in cTnT in every single runner with some changes noted as early 55 as 30 min after the start of exercise. In another study by the same group, cTnI was elevated in 56 most runners completing a high intensity, steady state 30 min run [10] . Taken together these 57 data would suggest that exercise-associated elevations of cTn are likely very common and 58 may occur very quickly with exercise. Despite this we still require additional data to 59 determine if a cTn-positive response is produced in response to exercise per se. Neither is it 60 clear whether very high exercise intensity (with concomitant shortened durations) may 61 mediate cTn release [4] . Finally, to date there is limited evidence as to whether the cTn 62 response to any exercise bout is a reproducible phenomenon. 63 64 Consequently, the aim of the current study was to assess; a) the appearance of cTnI after a 65 short bout (30 s) of "all-out" intense exercise, and b) to determine the stability of any exercise 66 related cTnI release in response to repeated bouts of high intensity exercise separated by 7 67 days recovery. 68 69
Materials and methods 70

Subjects and design 71
Eighteen apparently healthy, physically active, male university students volunteered 72 to participate (mean±SD age: 23±2.0 yr; body mass: 75.3±11 kg; stature 175.8±5.7 cm. The 73 study was approved by the University Ethics Committee and all participants provided written 74 informed consent form. All participants were full familiarised to the exercise test. The study 75 design was a repeated measures approach to biomarker assessment before and after 2 high 76 intensity exercise trials, separated by 7 days. For six weeks prior to data collection, and 77 throughout the study, participants maintained normal physical activity and dietary habits and 78 refrained from macro and micro-nutrient supplementation and/or the use of pharmaceutical 79 agents. Repeated assessments of cardiac biomarkers were made before, immediately after 80 and 24 h after each exercise bout. 81 82
Baseline measures 83
At baseline body mass, stature and body composition was determined using a 84 calibrated balanced weighing scales (Seca, UK), stadiometer (Seca, UK) and underwater 85 weighing procedures, respectively. Body density was assessed as described previously [11] . 86
Relative body fat was estimated from body density [12] . Residual lung volume was measured 87 using the simplified oxygen re-breathing method [13] . Fat free mass (FFM) was determined 88 by subtracting fat mass from total body mass. 89
90
The Acute Exercise Test 91
Participants performed 2 all-out 30 s cycle ergometer tests (Monark, 864, Monark-Crescent 92 AB, Varberg, Sweden). A force velocity test was performed one week prior to the 30s cycle 93 ergometer test to determine optimal resistive forces based on total body mass (TBM) and fat free mass 94 (FFM) . Briefly, the test consisted of six short maximal sprints (6-8 s) against randomly assigned 95 resistive forces (70, 75, 80, 85, 90 and 95 g.kg -1 ). Successive exercise bouts were separated by a 5 min 96 rest period. The resistive force that produced the highest PPO value for both TBM and FFM protocol 97 was used in the 30s test. Reliability of the optimal resistive force obtained for both TBM and FFM 98 protocol was determined using test retest methods. The order of the two 30s tests were 99 randomised and separated by 7 days. The cycle ergometer was set-up and calibrated in the 100 same way for all tests [14] . Saddle heights were adjusted to accommodate partial knee flexion 101 of between 170° to 175° (with 180° denoting a straight leg position) during the down stroke 102 and were consistent between repeated tests. Feet were firmly supported by toe clips and 103 straps. All subjects were instructed to remain seated during the test and were verbally 104 encouraged to perform maximally. All participants performed a standardised 5 min warm up 105 prior to experimental data collection [15] . Participants were given a rolling start at 60 rpm for 106 a 5 s period prior to resistive force application. On the command 'go', the subjects began to 107 pedal maximally, the resistive force applied simultaneously, and data capture initiated. intra-class correlation test. 160
Results 162
Values for performance data and peak heart rate generated during the study for the 163 two 30-s all out cycling trials are presented in Table 1 . Although there was a small but 164 significantly higher PPO with the FFM trial (c. 6.5%, P < 0.05), all other performance test 165 data were not different between trials (P > 0.05). Resting HR (68 beats.min -1 ) was the same 166 prior to both trials and peak HR attained was not different between trials. There was a 167 significant PVL between baseline and end-exercise (P < 0.05) that was not different between 168 trials (P > 0.05; Table 2) , with a return to baseline at 24 h post-test in both trials. This data 169 was used to correct data for blood borne parameters and biomarkers. Of note the blood lactate 170 concentrations rose with exercise (P < 0.05) and declined to baseline at 24 h post trial but 171 these changes were similar between trials (P > 0.05; Table 2 ). Biomarkers of sympathetic 172 neural activation, adrenaline and noradrenaline, were elevated post-exercise in both trials (P 173 < 0.05; Table 2) The key novel finding from this study is that short duration, high intensity cycling bouts (30 216 s) does not elicit a statistically or clinically significant increase in circulating cTnI during 217 immediate or late (24 hr post) recovery. Any small individual changes in response to exercise 218 are not consistent between trials and likely reflects the small biological variance in the cTnI 219 assay within a young, healthy cohort. 220
221
The extant sports medicine literature is replete with descriptive evidence of a rise in cTnI or 222 cTnT during or after bouts of endurance exercise [4] . This phenomenon has been reported in 223 different participant groups from the elite athlete to relatively untrained "weekend warrior" 224 [e.g. 7, 19] , from young adolescents to those in later life [e.g. 20, 21], across a range of 225 exercise bouts [22, 23] . What has characterised nearly all studies to date has been the 226 employment of endurance activity as it has been assumed that any cTn release with exercise 227 is due to some mechanism associated with the unremitting haemodymanic or metabolic stress 228 of prolonged activity on the heart. Recently, two studies have shed new and interesting 229 insights into exercise-related cTn appearance. Firstly, Middleton et al. (2008) [22] assayed 230 for cTn every 30 min during a treadmill-based marathon run and reported early (at 30 min) 231 elevation of cTn is some runners and an exercise-related cTn rise in all runners at some point 232 during the marathon. The same group then employed a high intensity 30 min run and 233 observed a rise in cTn in most participants [10] . Taken together it was hypothesised that a 234 cTn rise with exercise was potentially an inevitable phenomenon that would likely be 235 physiological in nature. The current study was conceived as an extension to the work of 236 Middleton et al. (2008) [22] and Shave et al. (2010b) [10] to determine if any exercise (per 237 se), even 30 s of high intensity cycling, could act as a stimulus to induce cTn changes in the 238 circulation. Whilst exercise may be a potent stimulus for cTn appearance in the systemic 239 circulation, the lack of a statistical or clinically significant rise in cTn after a 30s all-out cycle 240 trial in the current study would suggest that the total volume of exercise undertaken (30 s all-241 out) placed insufficient stress on the heart. Despite a rapid acceleration of HR with 30 s of all 242 out cycling, there is a subsequent quick deceleration of HR suggesting that the total 243 myocardial work and oxygen demand is very low in comparison to previous studies that have 244 employed endurance exercise, over many hours, days and even weeks [4] . The implications from this study are straightforward. Short bursts of high intensity activity 261 do not seem to result in an elevation in cTn either immediately or during later recovery from 262 exercise suggesting this type of exercise bout does not activate the mechanism(s) required to 263 elicit a statistically or clinically meaningful cTn response. Within the applied sports 264 medicine setting the appearance of large cTn increase (above clinical cut-offs 0.2 ng.ml -1 ) in 265 any participants or athletes with a recent history of exercise of less than 30 min should raise a 266 potential red flag for further clinical investigation. 267
268
As with all studies there as some limitations of note that should be followed up in on-going 269 studies. The data in the current study pertain only to young, healthy male participants. Given 270 that there may be different exercise-cTn responses in different participant populations this 271 study should be replicated in broader groups (age, sex, fitness status). Future work may 272 employ blood samples in recovery to provide conclusive evidence of a lack cTn response to 273 short bouts of physical activity. 274
275
In conclusion, a short duration, high intensity cycle trial does not result in an elevation of 276 cTnI immediately post-exercise or later during recovery (24 hr). The lack of a cTn response 277 was consistent over two cycling trials suggesting the overall response was repeatable. Small 278 between subject variance in cTn response to the exercise stimulus was clinically meaningless 279 and likely reflects a low level of biological variability in this assay in the current participants. 280 281 282
